We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MDB:NASDAQMongoDB, Inc. Analysis

Data as of 2026-05-21 - not real-time

$329.14

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

MongoDB (MDB) is trading at $329.14, roughly 9% above the DCF‑derived fair value of $230.5, indicating a premium valuation. The stock sits above its 20‑day SMA (≈$285.6) and 50‑day SMA (≈$266.3) but below the 200‑day SMA (≈$321.5), suggesting a short‑term upward bias within a longer‑term neutral framework. Technical momentum remains bullish, with the MACD line crossing above its signal (17.58 vs 11.77) and a positive histogram of 5.81, while the RSI has climbed to 70.5, edging into overbought territory. Volume is on an increasing trend, supporting the recent 20.7% one‑month price gain, and the market sentiment index reads “Extreme Greed” at 90.48. However, volatility is elevated at 58% over the past 30 days and beta of 1.5 points to heightened sensitivity to market swings. Current price is comfortably above the identified support at $240.6 but still below the resistance near $349.2, offering a sizable upside corridor.
Fundamentally, revenue surged 27% year‑over‑year to $2.46 bn, driven by strong adoption of the Atlas cloud‑DBaaS platform, and the company generated positive operating cash flow of $505 m and free cash flow of $463 m, underscoring solid cash generation despite a negative trailing EPS. The balance sheet is robust with $2.39 bn of cash against modest debt of $62 m, yielding a low debt‑to‑equity profile, but profitability metrics remain weak (negative net margin and ROE). The forward P/E of 46.5 sits above the industry average of 38.8, reinforcing the view that the market is pricing in continued high‑growth expectations. Analyst coverage is bullish, with a consensus “Buy” rating from 36 analysts and a median target price of $363, reflecting confidence in the growth trajectory. Given the blend of strong growth fundamentals, premium valuation, and elevated technical risk, the stock appears positioned for further upside if growth sustains, but investors should be cautious of potential pull‑backs from overbought conditions.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI approaching overbought levels
  • Positive MACD momentum
  • Upcoming earnings report on May 28

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 27% YoY revenue growth
  • Strong cash generation and low debt
  • Expanding Atlas cloud‑DBaaS adoption

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Large addressable market for cloud databases
  • High gross margin and recurring revenue model
  • Robust balance sheet supporting strategic investments

Key Metrics & Analysis

Financial Health

Revenue Growth26.70%
Profit Margin-2.89%
P/E Ratio46.5
ROE-2.48%
ROA-2.35%
Debt/Equity2.13
P/B Ratio9.0
Op. Cash Flow$505.1M
Free Cash Flow$463.3M
Industry P/E38.8

Technical Analysis

TrendNeutral
RSI70.5
Support$240.62
Resistance$349.21
MA 20$285.59
MA 50$266.27
MA 200$321.49
MACDBullish
VolumeIncreasing
Fear & Greed Index90.48

Valuation

Fair Value$230.49
Target Price$358.82
Upside/Downside9.02%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.52
Volatility58.28%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.